Vietnam Counts 20 Percent Increase In Foreign Pharmas Operating There (Vietnam)
This article was originally published in PharmAsia News
Executive Summary
The number of foreign pharmaceutical companies operating in Vietnam grew by nearly 20 percent this year, the first after the nation acceded to World Trade Organization rules. The head of the Vietnam Pharmaceutical Management Bureau said the number of foreign firms grew from 312 to 370 this year, with India now accounting for 81 of the total. Korea and China were next, but most of the companies are considered no larger than medium-size. The bureau also said drugs made in India and Korea accounted for 58 percent of the country's medicine imports, but they also accounted for most of the 19 drugs pulled from the market because of quality violations. (Click here for more
You may also be interested in...
MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In
The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.
Medtronic Launches Remote Live-Stream Surgery, New AI Capabilities
Medtronic will launch a new feature that allows for live streaming of surgical procedures in more than 20 countries and the addition of 14 AI-driven algorithms to enhance surgical workflow.
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.